Trial aims to ditch chemo for some breast cancer patients
NCT ID NCT04733118
Summary
This study is testing whether some patients with early-stage, HER2-positive breast cancer can be successfully treated without chemotherapy. It uses a combination of targeted antibody drugs given as an injection under the skin. The treatment plan is adjusted after surgery based on whether the cancer is completely gone, with the goal of controlling the disease while avoiding chemotherapy's side effects for as many people as possible.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AO Ospedale Civile Legnano
Milan, Italy
-
Azienda Ospedaliero Universitaria Di Bologna - Policlinico S.Orsola-Malpighi
Bologna, Italy
-
Azienda Ospedaliero-Universitaria di Parma
Parma, Italy
-
Békés county hospital
Békés, Hungary
-
Centro Oncológico de Galicia
A Coruña, 15009, Spain
-
Complejo Asistencial Universitario de León
León, Spain
-
Complejo Hospitalario de Jaen
Jaén, Spain
-
Consorcio Hospital General de Valencia
Valencia, Spain
-
Consorcio Hospitalario Provincial De Castelló
Castellon, 12002, Spain
-
Evangelisches Krankenhaus Bethesda
Duisburg, Germany
-
Fondazione Policlinico Universitario Agostino Gemelli
Roma, Italy
-
Hospital Arnau de Vilanova de Valencia
Valencia, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, Spain
-
Hospital Clínico San Carlos
Madrid, 28040, Spain
-
Hospital General Universitario de Alicante
Alicante, Spain
-
Hospital La Fe
Valencia, 46026, Spain
-
Hospital Quirón San Camilo- Ruber Juan Bravo
Madrid, Spain
-
Hospital Ramón y Cajal
Madrid, Spain
-
Hospital Universitari Arnau de Vilanova de Lleida
Lleida, Spain
-
Hospital Universitari Dexeus - Grupo Quirónsalud
Barcelona, Spain
-
Hospital Universitari San Joan de Reus
Reus, Tarragona, Spain
-
Hospital Universitario A Coruña
A Coruña, Spain
-
Hospital Universitario Clínico San Cecilio de Granada
Granada, Spain
-
Hospital Universitario Reina Sofia
Córdoba, Cordoba, 14004, Spain
-
Hospital Universitario Virgen del Rocio
Seville, Spain
-
Hospital Universitario de Basurto
Bilbao, 48013, Spain
-
Hospital Universitario de Torrejón
Torrejón, Spain
-
ICO L'Hospitalet - Instituto Catalán de Oncología
L'Hospitalet de Llobregat, Barcelona, 08007, Spain
-
Institut Català d' Oncologia Badalona (ICO)
Badalona, Spain
-
Instituto Valenciano de Oncología (IVO)
Valencia, 46009, Spain
-
Istituto Europeo di Oncologia - NC
Milan, Italy
-
Kliniken Essen Mitte
Essen, Germany
-
Klinikum Ernst von Bergmann
Potsdam, Germany
-
Ospedale Guglielmo da Saliceto
Piacenza, Italy
-
Ospedale San Gerardo
Monza, Italy
-
Praxisnetzwerk Hämatologie und intern. Onkologie
Cologne, Germany
-
Tolna County Balassa János Hospital
Szekszárd, Hungary
-
UMHAT Sveti Ivan Rilski EAD Department of Medical Oncology
Sofia, Bulgaria
-
Universitätsklinikum Essen Frauenklinik
Essen, Germany
-
Universitätsklinikum Mannheim GmbH
Manheim, Germany
-
VHIO Vall d'Hebron Institute of Oncology
Barcelona, Spain
Conditions
Explore the condition pages connected to this study.